A Scoping Review of Small Animal Image-guided Radiotherapy Research: Advances, Impact and Future Opportunities in Translational Radiobiology

Overview

Journal Clin Transl Radiat Oncol

Specialty Oncology

Date 2022 May 2

PMID 35496817

Authors

Kathryn H Brown

Mihaela Ghita

Ludwig J Dubois

Dirk De Ruysscher

Kevin M Prise

Frank Verhaegen

Karl T Butterworth

Affiliations

Soon will be listed here.

Abstract

Background And Purpose: To provide a scoping review of published studies using small animal irradiators and highlight the progress in preclinical radiotherapy (RT) studies enabled by these platforms since their development and commercialization in 2007.

Materials And Methods: PubMed searches and manufacturer records were used to identify 907 studies that were screened with 359 small animal RT studies included in the analyses. These articles were classified as biology or physics contributions and into subgroups based on research aims, experimental models and other parameters to identify trends in the preclinical RT research landscape.

Results: From 2007 to 2021, most published articles were biology contributions (62%) whilst physics contributions accounted for 38% of the publications. The main research areas of physics articles were in dosimetry and calibration (24%), treatment planning and simulation (22%), and imaging (22%) and the studies predominantly used phantoms (41%) or models (34%). The majority of biology contributions were tumor studies (69%) with brain being the most commonly investigated site. The most frequently investigated areas of tumor biology were evaluating radiosensitizers (33%), model development (30%) and imaging (21%) with cell-line derived xenografts the most common model (82%). 31% of studies focused on normal tissue radiobiology and the lung was the most investigated site.

Conclusions: This study captures the trends in preclinical RT research using small animal irradiators from 2007 to 2021. Our data show the increased uptake and outputs from preclinical RT studies in important areas of biology and physics research that could inform translation to clinical trials.

Citing Articles

Robust Automated Mouse Micro-CT Segmentation Using Swin UNEt TRansformers.

Jiang L, Xu D, Xu Q, Chatziioannou A, Iwamoto K, Hui S Bioengineering (Basel). 2025; 11(12.

PMID: 39768073 PMC: 11673508. DOI: 10.3390/bioengineering11121255.

A comparative analysis of preclinical computed tomography radiomics using cone-beam and micro-computed tomography scanners.

Brown K, Kerr B, Pettigrew M, Connor K, Miller I, Shiels L Phys Imaging Radiat Oncol. 2024; 31:100615.

PMID: 39157293 PMC: 11328005. DOI: 10.1016/j.phro.2024.100615.

Exploring Automated Contouring Across Institutional Boundaries: A Deep Learning Approach with Mouse Micro-CT Datasets.

Jiang L, Xu D, Xu Q, Chatziioannou A, Iwamoto K, Hui S ArXiv. 2024; .

PMID: 38855547 PMC: 11160888.

Feasibility and guidelines for the use of an injectable fiducial marker (BioXmark ) to improve target delineation in preclinical radiotherapy studies using mouse models.

Brown K, Ghita M, Prise K, Butterworth K F1000Res. 2024; 12:526.

PMID: 38799243 PMC: 11116939. DOI: 10.12688/f1000research.130883.1.

Dosimetric validation of SmART-RAD Monte Carlo modelling for x-ray cabinet radiobiology irradiators.

Hill M, Staut N, Thompson J, Verhaegen F Phys Med Biol. 2024; 69(9).

PMID: 38518380 PMC: 11031639. DOI: 10.1088/1361-6560/ad3720.

References

Vaniqui A, Walters B, Fonseca G, Verhaegen F . Dose to water versus dose to medium from cavity theory applied to small animal irradiation with kilovolt x-rays. Phys Med Biol. 2019; 64(16):165001. DOI: 10.1088/1361-6560/ab2db1. View

Paget V, Ben Kacem M, Dos Santos M, Benadjaoud M, Soysouvanh F, Buard V . Multiparametric radiobiological assays show that variation of X-ray energy strongly impacts relative biological effectiveness: comparison between 220 kV and 4 MV. Sci Rep. 2019; 9(1):14328. PMC: 6778087. DOI: 10.1038/s41598-019-50908-4. View

Wong J, Armour E, Kazanzides P, Iordachita I, Tryggestad E, Deng H . High-resolution, small animal radiation research platform with x-ray tomographic guidance capabilities. Int J Radiat Oncol Biol Phys. 2008; 71(5):1591-9. PMC: 2605655. DOI: 10.1016/j.ijrobp.2008.04.025. View

Koontz B, Verhaegen F, De Ruysscher D . Tumour and normal tissue radiobiology in mouse models: how close are mice to mini-humans?. Br J Radiol. 2016; 90(1069):20160441. PMC: 5605019. DOI: 10.1259/bjr.20160441. View

De Ruysscher D, Granton P, Lieuwes N, van Hoof S, Wollin L, Weynand B . Nintedanib reduces radiation-induced microscopic lung fibrosis but this cannot be monitored by CT imaging: A preclinical study with a high precision image-guided irradiator. Radiother Oncol. 2017; 124(3):482-487. DOI: 10.1016/j.radonc.2017.07.014. View

Granton P, Verhaegen F . On the use of an analytic source model for dose calculations in precision image-guided small animal radiotherapy. Phys Med Biol. 2013; 58(10):3377-95. DOI: 10.1088/0031-9155/58/10/3377. View

Liu F, Okunieff P, Bernhard E, Stone H, Yoo S, Coleman C . Lessons learned from radiation oncology clinical trials. Clin Cancer Res. 2013; 19(22):6089-100. PMC: 3965328. DOI: 10.1158/1078-0432.CCR-13-1116. View

Maity A, Mick R, Rengan R, Mitchell T, Amaravadi R, Schuchter L . A stratified phase I dose escalation trial of hypofractionated radiotherapy followed by ipilimumab in metastatic melanoma: long-term follow-up and final outcomes. Oncoimmunology. 2021; 10(1):1863631. PMC: 7872096. DOI: 10.1080/2162402X.2020.1863631. View

Dunne V, Ghita M, Small D, Coffey C, Weldon S, Taggart C . Inhibition of ataxia telangiectasia related-3 (ATR) improves therapeutic index in preclinical models of non-small cell lung cancer (NSCLC) radiotherapy. Radiother Oncol. 2017; 124(3):475-481. DOI: 10.1016/j.radonc.2017.06.025. View

10.

Corroyer-Dulmont A, Valable S, Fantin J, Chatre L, Toutain J, Teulier S . Multimodal evaluation of hypoxia in brain metastases of lung cancer and interest of hypoxia image-guided radiotherapy. Sci Rep. 2021; 11(1):11239. PMC: 8159969. DOI: 10.1038/s41598-021-90662-0. View

11.

Delaney G, Barton M . Evidence-based estimates of the demand for radiotherapy. Clin Oncol (R Coll Radiol). 2014; 27(2):70-6. DOI: 10.1016/j.clon.2014.10.005. View

12.

Porret E, Le Guevel X, Coll J . Gold nanoclusters for biomedical applications: toward in vivo studies. J Mater Chem B. 2020; 8(11):2216-2232. DOI: 10.1039/c9tb02767j. View

13.

Maity A, Mick R, Huang A, George S, Farwell M, Lukens J . A phase I trial of pembrolizumab with hypofractionated radiotherapy in patients with metastatic solid tumours. Br J Cancer. 2018; 119(10):1200-1207. PMC: 6251028. DOI: 10.1038/s41416-018-0281-9. View

14.

de Jong M, Essers J, van Weerden W . Imaging preclinical tumour models: improving translational power. Nat Rev Cancer. 2014; 14(7):481-93. DOI: 10.1038/nrc3751. View

15.

Chalmers A, Chan C, Sebag-Montefiore D . CTRad 10 Years On: From 10-point Plan to Top 10 Achievements. Clin Oncol (R Coll Radiol). 2019; 32(1):9-12. DOI: 10.1016/j.clon.2019.09.043. View

16.

Hackam D, Redelmeier D . Translation of research evidence from animals to humans. JAMA. 2006; 296(14):1731-2. DOI: 10.1001/jama.296.14.1731. View

17.

Gengenbacher N, Singhal M, Augustin H . Preclinical mouse solid tumour models: status quo, challenges and perspectives. Nat Rev Cancer. 2017; 17(12):751-765. DOI: 10.1038/nrc.2017.92. View

18.

Verhaegen F, van Hoof S, Granton P, Trani D . A review of treatment planning for precision image-guided photon beam pre-clinical animal radiation studies. Z Med Phys. 2014; 24(4):323-34. DOI: 10.1016/j.zemedi.2014.02.004. View

19.

Sharma R, Plummer R, Stock J, Greenhalgh T, Ataman O, Kelly S . Clinical development of new drug-radiotherapy combinations. Nat Rev Clin Oncol. 2016; 13(10):627-42. DOI: 10.1038/nrclinonc.2016.79. View

20.

van Hoof S, Granton P, Verhaegen F . Development and validation of a treatment planning system for small animal radiotherapy: SmART-Plan. Radiother Oncol. 2013; 109(3):361-6. DOI: 10.1016/j.radonc.2013.10.003. View